A legal challenge in Louisiana can proceed against a law classifying abortion pills, misoprostol and mifepristone, as Schedule IV controlled substances. Opponents argue that the law could cause life-threatening delays in medical emergencies, impacting how they obtain these drugs regularly.
Louisiana is the first state to classify misoprostol and mifepristone as Schedule IV drugs, which have stricter storage and obtaining requirements.
The classification arose from efforts by anti-abortion groups and Republican state lawmakers to make it harder to obtain these drugs.
